Duodenal ferroportin is up-regulated in patients with chronic hepatitis C.

Department of Digestive Diseases, The First Affiliated Hospital, Kunming Medical University, Kunming, Yunnan, China. Department of Cardiology, Beijing Hospital, Ministry of Health, Beijing, China. State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, CAS, Kunming, Yunnan, China.

PloS one. 2014;(10):e110658

Abstract

Hepatitis C virus (HCV) infection is a leading cause of liver-related mortality. Chronic hepatitis C (CHC) is frequently associated with disturbances in iron homeostasis, with serum iron and hepatic iron stores being elevated. Accumulating evidence indicates that chronic HCV infection suppresses expression of hepatic hepcidin, a key mediator of iron homeostasis, leading to iron overload conditions. Since hepcidin mediates degradation of ferroportin, a basolateral transporter involved in the release of iron from cells, diminished hepcidin expression probably leads to up-regulation of ferroportin-1 (Fpn1) in patients with CHC. In this study, we determined the protein levels of duodenal Fpn1, and found that its expression was significantly up-regulated in patients with CHC. The expression of duodenal Fpn1 is negatively correlated with mRNA levels of hepcidin, and positively correlated with serum iron parameters. Although iron is a critical factor for growth of a variety of pathogenic bacteria, our results suggest that iron overload in blood does not increase the infection rate of bacteria in patients with CHC.

Methodological quality

Publication Type : Clinical Trial

Metadata